Koninklijke DSM NV (DSM.AS) Stock Price, Quote, News and Overview
AMS:DSM - Euronext Amsterdam - NL0000009827 - Common Stock - Currency: EUR
DSM.AS Quote, Performance and Key Statistics
AMS:DSM (5/30/2023, 7:00:00 PM)
114.05
+0.15 (+0.13%)
The current stock price of DSM.AS is 114.05 EUR. In the past month the price increased by 1.11%. In the past year, price decreased by -27.19%.
DSM.AS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GIN.DE | GIVAUDAN-REG | 33.33 | 39.67B | ||
| SIKA.DE | SIKA AG-REG | 27.58 | 36.65B | ||
| DSFIR.AS | DSM-FIRMENICH AG | 101.53 | 25.36B | ||
| 6D81.DE | DUPONT DE NEMOURS INC | 15.15 | 24.60B | ||
| BRG.OL | BORREGAARD ASA | 22.55 | 18.58B | ||
| SY1.DE | SYMRISE AG | 29.59 | 14.14B | ||
| ELK.OL | ELKEM ASA | 25.72 | 12.83B | ||
| 1COV.DE | COVESTRO AG | N/A | 11.28B | ||
| AKZA.AS | AKZO NOBEL N.V. | 19.49 | 10.19B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 24.85 | 9.15B | ||
| SYENS.BR | SYENSQO SA | 12.75 | 7.01B | ||
| AMC.DE | ALBEMARLE CORP | N/A | 6.49B |
Related stock screener links
About DSM.AS
Company Profile
Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 20,682 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
Company Info
Koninklijke DSM NV
Het Overloon 1
Heerlen LIMBURG NL
Employees: 20682
Phone: 31455788111.0
Koninklijke DSM NV / DSM.AS FAQ
What is the stock price of Koninklijke DSM NV today?
The current stock price of DSM.AS is 114.05 EUR. The price increased by 0.13% in the last trading session.
What is the ticker symbol for Koninklijke DSM NV stock?
The exchange symbol of Koninklijke DSM NV is DSM and it is listed on the Euronext Amsterdam exchange.
On which exchange is DSM.AS stock listed?
DSM.AS stock is listed on the Euronext Amsterdam exchange.
What is the price forecast or stock price prediction for Koninklijke DSM NV stock?
24 analysts have analysed DSM.AS and the average price target is 151.14 EUR. This implies a price increase of 32.52% is expected in the next year compared to the current price of 114.05. Check the Koninklijke DSM NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Koninklijke DSM NV worth?
Koninklijke DSM NV (DSM.AS) has a market capitalization of 568.64M EUR. This makes DSM.AS a Small Cap stock.
How many employees does Koninklijke DSM NV have?
Koninklijke DSM NV (DSM.AS) currently has 20682 employees.
What are the support and resistance levels for Koninklijke DSM NV (DSM.AS) stock?
Koninklijke DSM NV (DSM.AS) has a support level at 113.92 and a resistance level at 114.11. Check the full technical report for a detailed analysis of DSM.AS support and resistance levels.
Is Koninklijke DSM NV (DSM.AS) expected to grow?
The Revenue of Koninklijke DSM NV (DSM.AS) is expected to grow by 9.64% in the next year. Check the estimates tab for more information on the DSM.AS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy Koninklijke DSM NV (DSM.AS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DSM.AS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DSM.AS, evaluating the profitability, health, valuation and growth aspects
- Koninklijke DSM NV (DSM.AS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Koninklijke DSM NV (DSM.AS) Sales and EPS estimates to see what analysts future expectations are.
- Koninklijke DSM NV (DSM.AS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Koninklijke DSM NV (DSM.AS) Insider and Institutional Ownership to learn about the owners and their transactions.
- Koninklijke DSM NV (DSM.AS) Stock Chart to make your own analysis
- Koninklijke DSM NV (DSM.AS) Latest news and press-releases to stay up to date.
Does Koninklijke DSM NV (DSM.AS) stock pay dividends?
Koninklijke DSM NV (DSM.AS) has a dividend yield of 2.31%. The yearly dividend amount is currently 1.99. Check the full fundamental report for a detailed analysis of DSM.AS dividend history, reliability and sustainability.
What is the Price/Earnings (PE) ratio of Koninklijke DSM NV (DSM.AS)?
The PE ratio for Koninklijke DSM NV (DSM.AS) is 11.64. This is based on the reported non-GAAP earnings per share of 9.8 and the current share price of 114.05 EUR. Check the full fundamental report for a full analysis of the valuation metrics for DSM.AS.
DSM.AS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to DSM.AS. When comparing the yearly performance of all stocks, DSM.AS is a bad performer in the overall market: 86.44% of all stocks are doing better.
DSM.AS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DSM.AS. Both the profitability and the financial health of DSM.AS get a neutral evaluation. Nothing too spectacular is happening here.
DSM.AS Financial Highlights
Over the last trailing twelve months DSM.AS reported a non-GAAP Earnings per Share(EPS) of 9.8. The EPS increased by 1.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.19% | ||
| ROA | 9.73% | ||
| ROE | 15.77% | ||
| Debt/Equity | 0.28 |
DSM.AS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to DSM.AS. The Buy consensus is the average rating of analysts ratings from 24 analysts.
For the next year, analysts expect an EPS growth of -17.84% and a revenue growth 9.64% for DSM.AS